REDEMPTION AGREEMENTRedemption Agreement • November 14th, 2007 • Narek Pharmaceuticals • Blank checks • New York
Contract Type FiledNovember 14th, 2007 Company Industry JurisdictionThis Agreement (the “Agreement”) is made as of the 14th day of November, 2007 by and between Narek Pharmaceuticals, Inc., a Delaware corporation having its offices at 933 Mamaroneck Avenue, Suite 103, Mamaroneck, NY 10543 (the “Issuer”) and Anna Kazanchyan, M.D., with an address at 25 Allegra Court, White Plains, NY 10603 (the “Seller”).
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • November 14th, 2007 • Narek Pharmaceuticals • Blank checks • Delaware
Contract Type FiledNovember 14th, 2007 Company Industry JurisdictionAGREEMENT entered into as of the 14th day of November, 2007, by and between Narek Pharmaceuticals, Inc., a Delaware corporation with an address at 933 Mamaroneck Avenue, Suite 103, Mamaroneck, NY 10543 (the “Company”) and Genesis Holdings, Inc., a Texas corporation with an address at 10010 San Pedro Avenue, Suite 310, San Antonio, TX 78216 (the “Purchaser”).
ESCROW AGREEMENTEscrow Agreement • November 14th, 2007 • Narek Pharmaceuticals • Blank checks • New York
Contract Type FiledNovember 14th, 2007 Company Industry JurisdictionTHIS ESCROW AGREEMENT (this “Agreement”) is made as of November 14, 2007, by and among Anna Kazanchyan, M.D., with an address at 25 Allegra Court, White Plains, NY 10603 (“Kazanchyan”), Genesis Holdings, Inc., a Texas corporation with an address at 10010 San Pedro Avenue, Suite 310, San Antonio, TX 78216 (“Genesis”), Narek Pharmaceuticals, Inc., a Delaware corporation with an address at 933 Mamaroneck Avenue, Suite 103, Mamaroneck, NY 10543 (the “Company”) and Feldman Weinstein & Smith LLP, having an address at 420 Lexington Avenue, Suite 2620, New York, NY 10170 (the “Escrow Agent”). Capitalized terms used but not defined herein shall have the meanings set forth in the Promissory Notes, Common Stock Purchase Agreement and Redemption Agreement referred to in the recitals. Hereinafter, Kazanchyan, Genesis and the Company shall be referred to as the “Parties”, each a “Party.”